-
1
-
-
0036806622
-
The TNF-TNF receptor system
-
Hehlgans T, Mannel DN (2002) The TNF-TNF receptor system. Biol Chem 383:1581-1585
-
(2002)
Biol Chem
, vol.383
, pp. 1581-1585
-
-
Hehlgans, T.1
Mannel, D.N.2
-
2
-
-
17944381638
-
Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation
-
Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ et al (2001) Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15:533-543
-
(2001)
Immunity
, vol.15
, pp. 533-543
-
-
Ruuls, S.R.1
Hoek, R.M.2
Ngo, V.N.3
McNeil, T.4
Lucian, L.A.5
Janatpour, M.J.6
-
3
-
-
0032969285
-
Tumor necrosis factor receptor and Fas signaling mechanisms
-
Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331-367
-
(1999)
Annu Rev Immunol
, vol.17
, pp. 331-367
-
-
Wallach, D.1
Varfolomeev, E.E.2
Malinin, N.L.3
Goltsev, Y.V.4
Kovalenko, A.V.5
Boldin, M.P.6
-
4
-
-
0036121098
-
TNF receptor subtype signalling: Differences and cellular consequences
-
MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14:477-492
-
(2002)
Cell Signal
, vol.14
, pp. 477-492
-
-
MacEwan, D.J.1
-
5
-
-
0037204948
-
TNF-R1 signaling: A beautiful pathway
-
Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296(5573):1634-1635
-
(2002)
Science
, vol.296
, Issue.5573
, pp. 1634-1635
-
-
Chen, G.1
Goeddel, D.V.2
-
6
-
-
0642366755
-
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
-
Mikuls TR, Weaver AL (2003) Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis. Curr Rheumatol Rep 5:270-277
-
(2003)
Curr Rheumatol Rep
, vol.5
, pp. 270-277
-
-
Mikuls, T.R.1
Weaver, A.L.2
-
7
-
-
0042925466
-
Infliximab treatment of rheumatoid arthritis and Crohn's disease
-
Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH (2003) Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother 37:1256-1265
-
(2003)
Ann Pharmacother
, vol.37
, pp. 1256-1265
-
-
Nahar, I.K.1
Shojania, K.2
Marra, C.A.3
Alamgir, A.H.4
Anis, A.H.5
-
8
-
-
0041826789
-
Effectiveness of psoriatic arthritis therapies
-
Gladman DD (2003) Effectiveness of psoriatic arthritis therapies. Semin Arthritis Rheum 33:29-37
-
(2003)
Semin Arthritis Rheum
, vol.33
, pp. 29-37
-
-
Gladman, D.D.1
-
9
-
-
0038302429
-
Treatment of primary systemic vasculitis with TNF alpha-antagonists
-
Gause A, Arbach O, Lamprecht P (2003) Treatment of primary systemic vasculitis with TNF alpha-antagonists. Z Rheumatol 62:228-234
-
(2003)
Z Rheumatol
, vol.62
, pp. 228-234
-
-
Gause, A.1
Arbach, O.2
Lamprecht, P.3
-
10
-
-
2642513223
-
Developing a new generation of TNF-α antagonists for the treatment of rheumatoid arthritis
-
Fleischmann R, Shealy D (2003) Developing a new generation of TNF-α antagonists for the treatment of rheumatoid arthritis. Mol Interv 3:310-318
-
(2003)
Mol Interv
, vol.3
, pp. 310-318
-
-
Fleischmann, R.1
Shealy, D.2
-
11
-
-
0033524159
-
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized phase III trial
-
ATTRACT Study Group
-
Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M et al (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. Lancet 354(9194):1932-1939
-
(1999)
Lancet
, vol.354
, Issue.9194
, pp. 1932-1939
-
-
Maini, R.1
St Clair, E.W.2
Breedveld, F.3
Furst, D.4
Kalden, J.5
Weisman, M.6
-
12
-
-
1542369183
-
Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease
-
Sandborn WJ (2003) Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease. Curr Gastroenterol Rep 5:501-505
-
(2003)
Curr Gastroenterol Rep
, vol.5
, pp. 501-505
-
-
Sandborn, W.J.1
-
13
-
-
4544317926
-
Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab
-
Chew AL, Bennett A, Smith CH, Barker J, Kirkham B (2004) Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. Br J Dermatol 151:492-496
-
(2004)
Br J Dermatol
, vol.151
, pp. 492-496
-
-
Chew, A.L.1
Bennett, A.2
Smith, C.H.3
Barker, J.4
Kirkham, B.5
-
14
-
-
0034729950
-
Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomized trial
-
Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet 356:385-390
-
(2000)
Lancet
, vol.356
, pp. 385-390
-
-
Mease, P.J.1
Goffe, B.S.2
Metz, J.3
VanderStoep, A.4
Finck, B.5
Burge, D.J.6
-
15
-
-
0042072982
-
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three-month, randomized, placebo-controlled trial
-
Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G et al (2003) Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum 48:2224-2233
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2224-2233
-
-
Braun, J.1
Brandt, J.2
Listing, J.3
Zink, A.4
Alten, R.5
Burmester, G.6
-
16
-
-
0037029430
-
Treatment of active ankylosing spondylitis with infliximab: A randomized controlled multicentre trial
-
Braun J, Brandt J, Listing J, Zink A, Alten R, Gromnica-Ihle E et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 359(9313):1187-1193
-
(2002)
Lancet
, vol.359
, Issue.9313
, pp. 1187-1193
-
-
Braun, J.1
Brandt, J.2
Listing, J.3
Zink, A.4
Alten, R.5
Gromnica-Ihle, E.6
-
17
-
-
0036852331
-
Efficacy of infliximab in refractory ankylosing spondylitis: Results of a six-month open-label study
-
Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E et al (2002) Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology 41:1280-1285
-
(2002)
Rheumatology
, vol.41
, pp. 1280-1285
-
-
Breban, M.1
Vignon, E.2
Claudepierre, P.3
Devauchelle, V.4
Wendling, D.5
Lespessailles, E.6
-
18
-
-
0042887352
-
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: A new perspective on the role of host defence in the pathogenesis of the disease?
-
Baeten D, Kruithof E, Bosch F, Van den Bossche N, Herssens A, Mielants H et al (2003) Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis 62:829-834
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 829-834
-
-
Baeten, D.1
Kruithof, E.2
Bosch, F.3
Van Den Bossche, N.4
Herssens, A.5
Mielants, H.6
-
19
-
-
0043203001
-
Severe neutropenia and thrombocytopenia associated with infliximab
-
Vidal F, Fontova R, Richart C (2003) Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 139:E238-E239
-
(2003)
Ann Intern Med
, vol.139
-
-
Vidal, F.1
Fontova, R.2
Richart, C.3
-
20
-
-
0037434552
-
Influence of immunogenicity on the long term efficacy of infliximab in Crohn's disease
-
Baert F, Noman M, Vermeire S, Van Assche G, D'Haens G, Carbonez A et al (2003) Influence of immunogenicity on the long term efficacy of infliximab in Crohn's disease. N Engl J Med 348:601-608
-
(2003)
N Engl J Med
, vol.348
, pp. 601-608
-
-
Baert, F.1
Noman, M.2
Vermeire, S.3
Van Assche, G.4
D'Haens, G.5
Carbonez, A.6
-
21
-
-
0033763979
-
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: Findings in open-label and randomized placebo-controlled trials
-
Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN (2000) Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 43:2383-2390
-
(2000)
Arthritis Rheum
, vol.43
, pp. 2383-2390
-
-
Charles, P.J.1
Smeenk, R.J.2
De Jong, J.3
Feldmann, M.4
Maini, R.N.5
-
22
-
-
0038109994
-
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: A prospective cohort study
-
Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N et al (2003) Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 125:32-39
-
(2003)
Gastroenterology
, vol.125
, pp. 32-39
-
-
Vermeire, S.1
Noman, M.2
Van Assche, G.3
Baert, F.4
Van Steen, K.5
Esters, N.6
-
23
-
-
16344383360
-
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: A two-year prospective study
-
Ferraro-Peyret C, Coury F, Tebib JG, Bienvenu J, Fabien N (2004) Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study. Arthritis Res Ther 6:R535-R543
-
(2004)
Arthritis Res Ther
, vol.6
-
-
Ferraro-Peyret, C.1
Coury, F.2
Tebib, J.G.3
Bienvenu, J.4
Fabien, N.5
-
24
-
-
0026900423
-
The clinical significance of HAMA in patients treated with mouse monoclonal antibodies
-
Frodin JE, Lefvert AK, Mellstedt H (1992) The clinical significance of HAMA in patients treated with mouse monoclonal antibodies. Cell Biophys 21:153-165
-
(1992)
Cell Biophys
, vol.21
, pp. 153-165
-
-
Frodin, J.E.1
Lefvert, A.K.2
Mellstedt, H.3
-
25
-
-
0033855859
-
Clinical trials of antibody therapy
-
Glennie MJ, Johnson PW (2000) Clinical trials of antibody therapy, Immunol Today 21:403-410
-
(2000)
Immunol Today
, vol.21
, pp. 403-410
-
-
Glennie, M.J.1
Johnson, P.W.2
-
27
-
-
0028579768
-
A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
-
Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281-2285
-
(1994)
J Rheumatol
, vol.21
, pp. 2281-2285
-
-
Calin, A.1
Garrett, S.2
Whitelock, H.3
Kennedy, L.G.4
O'Hea, J.5
Mallorie, P.6
-
28
-
-
0030074829
-
An update on the bath ankylosing spondylitis disease activity and functional indices (BASDAI, BASFI): Excellent Cronbach's alpha scores
-
Biasi D, Carletto A, Caramaschi P, Bambara LM (1996) An update on the bath ankylosing spondylitis disease activity and functional indices (BASDAI, BASFI): excellent Cronbach's alpha scores. J Rheumatol 23:407-408
-
(1996)
J Rheumatol
, vol.23
, pp. 407-408
-
-
Biasi, D.1
Carletto, A.2
Caramaschi, P.3
Bambara, L.M.4
-
29
-
-
0033984226
-
Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells
-
Aybay C, Imir T (2000) Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells. J Immunol Methods 233:77-81
-
(2000)
J Immunol Methods
, vol.233
, pp. 77-81
-
-
Aybay, C.1
Imir, T.2
-
30
-
-
3543106683
-
Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab
-
Miele E, Markowitz JE, Mamula P, Baldassano RN (2004) Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab. J Pediatr Gastroenterol Nutr 38:502-508
-
(2004)
J Pediatr Gastroenterol Nutr
, vol.38
, pp. 502-508
-
-
Miele, E.1
Markowitz, J.E.2
Mamula, P.3
Baldassano, R.N.4
-
31
-
-
0242413804
-
A novel monoclonal antibody design for radioimmunotherapy
-
Forero A, Meredith RF, Khazaeli MB, Carpenter DM, Shen S, Thornton J et al (2003) A novel monoclonal antibody design for radioimmunotherapy. Cancer Biother Radiopharm 18:751-759
-
(2003)
Cancer Biother Radiopharm
, vol.18
, pp. 751-759
-
-
Forero, A.1
Meredith, R.F.2
Khazaeli, M.B.3
Carpenter, D.M.4
Shen, S.5
Thornton, J.6
-
32
-
-
0038476357
-
Immunogenicity of therapeutic monoclonal antibodies
-
Pendley C, Schantz A, Wagner C (2003) Immunogenicity of therapeutic monoclonal antibodies. Curr Opin Mol Ther 5:172-179
-
(2003)
Curr Opin Mol Ther
, vol.5
, pp. 172-179
-
-
Pendley, C.1
Schantz, A.2
Wagner, C.3
-
33
-
-
0037234032
-
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
-
Gottlieb AB, Masud S, Ramamurthi R, Abdulghani A, Romano P, Chaudhari U et al (2003) Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris. J Am Acad Dermatol 48:68-75
-
(2003)
J Am Acad Dermatol
, vol.48
, pp. 68-75
-
-
Gottlieb, A.B.1
Masud, S.2
Ramamurthi, R.3
Abdulghani, A.4
Romano, P.5
Chaudhari, U.6
-
34
-
-
0031660364
-
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
-
Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD et al (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41:1552-1563
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1552-1563
-
-
Maini, R.N.1
Breedveld, F.C.2
Kalden, J.R.3
Smolen, J.S.4
Davis, D.5
Macfarlane, J.D.6
-
35
-
-
0342530626
-
Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response
-
USA
-
LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB et al (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci USA 86:4220-4224
-
(1989)
Proc Natl Acad Sci
, vol.86
, pp. 4220-4224
-
-
LoBuglio, A.F.1
Wheeler, R.H.2
Trang, J.3
Haynes, A.4
Rogers, K.5
Harvey, E.B.6
|